AstraZeneca has provided a sponsorship grant towards this independent programme.
Expert guidance regarding the optimal management of patients with CML receiving tyrosine kinase inhibitor (TKI) therapy from Clinical Care Options.
Expert commentary from Farrukh Awan, MD, on the updated CCO online treatment decision support tool for CLL based on recent therapeutic advances
In this downloadable slideset, you can review the most recent clinical data on novel BCMA-targeted agents in the treatment of multiple myeloma.
Expert-authored, CME-certified online educational activity covering the most recent clinical data on BCMA-targeted agents for treating multiple myeloma
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.